A retrospective analysis of metaplastic triple negative breast cancer response to sacituzumab govitecan and candidacy for targeted therapy.

Authors: Shivahamy Maheswaran, Aylin S. Dedeoglu, Andrzej Niemierko, Rachel Occhiogrosso Abelman, Rachel Jimenez, Neelima Vidula, Seth Andrew Wander, Laura Spring, Leif Ellisen, Steven J. Isakoff, Aditya Bardia, Arielle J Medford

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e13015

Source: Full article

---

Abstract

e13015